| http://www.w3.org/ns/prov#value | - Under the terms of the agreement, Zymeworks has granted Lilly a worldwide license to the Azymetric??? platform to develop and commercialize therapeutic candidates in exchange for up to US $375 million in milestones and other payments, plus tiered sales royalties.
|
